Chemed (CHE) continues to be hurt by macroeconomic impacts on business, seasonality factors and the competitive landscape. The challenges within the Roto-Rooter business dented the third quarter result. The stock carries a Zacks Rank #4 (Sell) at present.Concerning Factors Pulling CHE Stock DownThe Roto-Rooter business has been navigating the ongoing headwinds in consumer sentiment and consumer spending within its sector. Recently, hit by the business’s ongoing challenges, management has decided to look for ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended September 30, 2024 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 31-0791746 (State or other jurisdiction of incorporation or organization) (IRS ...

Chemed Corporation (NYSE:CHE) Q3 2024 Earnings Conference Call October 30, 2024 10:00 AM ET Company Participants Holley Schmidt - Assistant Controller Kevin McNamara - President and Chief Executive Officer Mike Witzeman - Chief Financial Officer Nick Westfall - Chairman and Chief Executive Officer, VITAS Healthcare Corporation Conference Call Participants Ben Hendrix - RBC Capital Markets Joanna Gajuk - Bank of America Operator Good day and thank you for standing by. Welcome to the Chemed Corporation Third ...

Chemed Corporation (CHE) reported third-quarter 2024 adjusted earnings per share (EPS) of $5.64, which rose 6% year over year. However, the figure missed the Zacks Consensus Estimate by 2.1%. The company's GAAP EPS was $5.00, up 1.4% from last year's reported figure. Find the latest EPS estimates and surprises on Zacks Earnings Calendar. Following the earnings announcement, CHE stock rose marginally 0.2% yesterday. CHE's Revenues in Detail Revenues in the reported quarter improved 7.4% year over year to $60 ...

Chemed (CHE) came out with quarterly earnings of $5.64 per share, missing the Zacks Consensus Estimate of $5.76 per share. This compares to earnings of $5.32 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of -2.08%. A quarter ago, it was expected that this operator of the Roto-Rooter plumbing service and Vitas Healthcare hospices would post earnings of $5.54 per share when it actually produced earnings of $5.47, delivering a sur ...

Picture 2 CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Reports Third-Quarter 2024 Results CINCINNATI, October 29, 2024—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2024, versus the comparable prior-year period. Change ...

Chemed Corporation (CHE) is expected to grow in the upcoming quarters, backed by the prospects of the VITAS business. Strength within the company's Roto-rooter brand looks impressive. Meanwhile, Chemed's operations are vulnerable to a dull macroeconomic environment, which can adversely impact its financial results. Competitive disadvantages also add to the worry. In the past year, this Zacks Rank #3 (Hold) stock has risen 11.7% compared with the industry's 33.9% growth and the S&P 500 composite's 32.3% incr ...

It has been about a month since the last earnings report for Chemed (CHE) . Shares have added about 5.7% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Chemed due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers. Chemed Q2 Earnings Miss Estimates, Margins Rise Chemed Co ...

1 IF D H HT T 100 - 100 1 i T 1 Pgiam/iStock via Getty Images Investment update Following my last publication on Chemed Corporation (NYSE:CHE) the stock is flat, and I am reiterating my buy rating on the stock after its Q2 FY'24 earnings. The last publication, titled "Continues to compound shareholder value at double-digit returns" advocated to size into CHE based on a number of factors, all of which are still relevant today, namely: CHE is a long-term compounder with a cycle of producing high returns on th ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both. The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor. It also includes access to the Zacks Style Scores ...